1
Home
Companies

Conatus Pharmaceuticals

Conatus Pharmaceuticals
Leadership team

Richard W. Pascoe (CEO, President & Director)

Brian M. Satz (Independent Director)

Steven J. Mento (Executive Chairman, Interim President & CEO)

Products/ Services
Biotechnology, Health Care, Therapeutics
Number of Employees
0 - 50
Headquarters
San Diego, California, United States
Established
2005
Company Registration
SEC CIK number: 0001383701
Traded as
NASDAQ:CNAT
Social Media
URL
www.conatuspharma.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Conatus Pharmaceuticals is a biopharmaceutical company focusing on the development and commercialization of novel medicines to treat liver diseases.
History

Conatus Pharmaceutials was established in 2005 with a vision of developing effective treatment for patients with chronic liver diseases. The company has developed a well-defined research and development platform using proprietary technologies focusing on caspase inhibitors for a range of liver diseases.

Mission
To make a positive difference in the lives of people affected by serious liver diseases.
Vision
Enable the need for innovation through science-driven advances in the development of therapies for liver diseases.
Key Team

David Easter (Member of Scientific Advisory Board)

Dale P. DeVore (Member of the Scientific Advisory Board)

Daniel L. Kisner (Independent Director)

Susan R. Windham-Bannister (Independent Director)

Neil Scott Sadick (Member of the Scientific Advisory Board)

Craig L. Ziering (Member of Scientific Advisory Board)

Rochelle Fuhrmann (Independent Director)

Jonathan Jackson (Independent Director)

David H. Crean (Lead Independent Director)

Recognition and Awards
Conatus Pharmaceuticals has recently won multiple awards for its breakthrough research on drug development for liver diseases, including the 2018 Drug of the Year Award from the European Liver Disease Forum and the 2019 Research Excellence Award from the National Institutes of Health.
References

https://in.investing.com/equities/conatus-pha-opinion/2

https://www.crunchbase.com/organization/conatus-pharmaceuticals

www.conatuspharma.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Conatus Pharmaceuticals
Leadership team

Richard W. Pascoe (CEO, President & Director)

Brian M. Satz (Independent Director)

Steven J. Mento (Executive Chairman, Interim President & CEO)

Products/ Services
Biotechnology, Health Care, Therapeutics
Number of Employees
0 - 50
Headquarters
San Diego, California, United States
Established
2005
Company Registration
SEC CIK number: 0001383701
Traded as
NASDAQ:CNAT
Social Media
URL
www.conatuspharma.com